COMMUNIQUÉS West-GlobeNewswire

Cingulate Announces Adjournment of Special Meeting

23/08/2024 - 22:45

KANSAS CITY, Kan., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), (“Cingulate” or the “Company”), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery [...]

HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction

23/08/2024 - 22:30

This release has made a correction to a release issued under the same headline on August 14, 2024, by HCW Biologics, Inc. (NASDAQ: HCWB), to show the amount included in the condensed interim balance sheet for Cash and [...]

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

23/08/2024 - 22:30

BRISBANE, Calif., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class 1 targeted and immune-mediated therapeutics to fight cancer [...]

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

23/08/2024 - 22:30

CAMBRIDGE, Mass., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with [...]

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

23/08/2024 - 22:30

PROVIDENCE, Rhode Island, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. ( NASDAQ : OCEA), today announced that on August 19, 2024, it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that [...]

ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics

23/08/2024 - 22:30

WESTMINSTER, Colo., Aug. 23, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ: ABIO) (“ARCA”) today announced that its Board of Directors (the “Board”) has approved a reverse stock split of ARCA’s common stock at a [...]

SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome

23/08/2024 - 22:09

SciSparc to conduct the trial at the Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School in Germany and Tel Aviv Sourasky Medical Center in Israel TEL AVIV, Israel, Aug. 23, 2024 ( [...]

NurExone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Conferences

23/08/2024 - 22:03

Participation in the events in Boston and New York highlights the Company's prominence in regenerative medicine and exosome technology TORONTO and HAIFA, Israel, Aug. 23, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc [...]

Sienna Senior Living Inc. Announces DBRS Credit Rating Update

23/08/2024 - 21:43

MARKHAM, Ontario, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) announced the confirmation by Dominion Bond Rating Service (“DBRS”) of the Company’s BBB Issuer [...]

bioLytical Announces Final Results of Substantial Issuer Bid

23/08/2024 - 20:56

VANCOUVER, British Columbia, Aug. 23, 2024 (GLOBE NEWSWIRE) -- bioLytical Laboratories Inc. (the “Company” or “bioLytical”) announces that it has taken up and paid for 18,234,667 common shares (the “Purchased Shares”) [...]

NMDP Named ‘Best Place to Work’ Fourth Year in a Row

23/08/2024 - 18:58

Global cell therapy nonprofit honored in top 3 of the 'extra large' companies, recognizing its exceptional employees, workplace culture and life-saving mission MINNEAPOLIS, Aug. 23, 2024 (GLOBE NEWSWIRE) -- NMDP SM , a [...]

Sienna Files Final Short Form Prospectus in Connection with Bought Deal Equity Financing and Obtains Receipt of Final Prospectus

23/08/2024 - 18:54

Final Short Form Prospectus is Accessible on SEDAR+ NOT FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MARKHAM, Ontario, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc [...]

Fagron’s share buy-back program: Weekly update

23/08/2024 - 18:45

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 23 August 2024 – 6PM CET Fagron’s share buy-back program: Weekly update In the period from 19 August 2024 through 23 August 2024, Fagron purchased 34 [...]

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

23/08/2024 - 18:00

COPENHAGEN, Denmark, August 23, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial [...]

Eyenovia Announces Closing of Public Offering

23/08/2024 - 17:42

NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (“Eyenovia” or the “Company”) (NASDAQ: EYEN), a commercial-stage ophthalmic company, announced today the closing of its public offering of 12,850,000 shares of [...]

Thermo Scientific™ VisionMate™ HSX High Speed Barcode Reader Integrates with eLabNext Platform

23/08/2024 - 17:33

BOSTON, Aug. 23, 2024 (GLOBE NEWSWIRE) -- eLabNext , an Eppendorf Group Company offering a flexible Digital Laboratory Platform equipped with a Laboratory Inventory Management System (LIMS) and Electronic Lab Notebook ( [...]

Vistin Pharma ASA: Mandatory notification of trade

23/08/2024 - 16:06

Saga Pure ASA has on 23 August 2024 purchased 300,000 shares in Vistin Pharma ASA at NOK 22,50 per share. After the transaction Saga Pure ASA has a holding of 400,000 shares, corresponding to 0.9 % ownership. Saga Pure [...]

BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA OPERATIONS, LLC. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY.

23/08/2024 - 16:00

GRANTS, NEW MEXICO, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the “Company”) today announced that it has signed a letter of intent to supply its DEA-approved marijuana [...]

Wendy Vlieks Appointed as President of The Genome Partnership, Succeeding Leisa Zigman

23/08/2024 - 16:00

Experienced Communications Leader to Drive Growth and Educational Initiatives ST. LOUIS, Aug. 23, 2024 (GLOBE NEWSWIRE) -- The Genome Partnership is pleased to announce the appointment of Wendy Vlieks, former VP of [...]